orphenadrine has been researched along with pk 11195 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Camarasa, J; Camins, A; Canudas, AM; Escubedo, E; Pallàs, M; Pubill, D; Sureda, FX; Verdaguer, E | 1 |
1 other study(ies) available for orphenadrine and pk 11195
Article | Year |
---|---|
Orphenadrine prevents 3-nitropropionic acid-induced neurotoxicity in vitro and in vivo.
Topics: Animals; Antihypertensive Agents; Blotting, Western; Body Weight; Cell Survival; Cerebellum; Corpus Striatum; Disease Models, Animal; Drug Interactions; Isoquinolines; Male; Mortality; Muscarinic Antagonists; Neurotoxicity Syndromes; Nitro Compounds; Orphenadrine; Propionates; Radioligand Assay; Rats; Rats, Sprague-Dawley; Tritium | 2001 |